RC
Therapeutic Areas
NTC Pipeline
| Drug | Indication | Phase |
|---|---|---|
| NT014 | Prevention & Treatment of Post-Cataract Infection | Development |
| Imperial Line | Dry Eye Disease | Commercial/Development |
| Glaucoma Portfolio (Acquired) | Glaucoma | Commercial |
| TiAB | Vaginal Antimicrobial / AMR Prevention | Research/Commercial |